Altruist Biologics' Hangzhou ADC facility approved for segmented production
Northwest Biotherapeutics presents updated DCVax-L Phase III trial survival data for glioblastoma
Lynk Pharmaceuticals reports first patient dosed in Phase II clinical trial for vitiligo treatment
HanchorBio plans combination research with late-stage cancer drug resistance specialist InxMed
Keenova reports positive Phase 3 results for XIAFLEX in plantar fibromatosis
GE HealthCare and Mayo Clinic launch prostate cancer theranostics research study
Helix partners with AstraZeneca to support genomic research for drug discovery and development
Insilico initiates Rentosertib Phase III clinical trial for idiopathic pulmonary fibrosis
Wiley announces launch of Advanced Immunology open access journal
Ascletis submits two IND applications to US FDA for obesity treatments
Aurinia initiates PRESERVE Phase 4 study of LUPKYNIS combination therapy in lupus nephritis
Anixa Biosciences advances ovarian cancer CAR-T trial to highest dose level
Taiwan biomedical startups hold over 100 business meetings at BIO 2026